Late effects after AlloHCT for pediatric patients with non-malignant diseases.
Study #: LE16-02b
Study Status: Published
Presentation(s)
2021, ASH (Oral)
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study.
Citation
Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton BK, Schoemans H, Abraham AA, Agrawal V, Auletta JJ, Badawy SM, Beitinjaneh A, Bhatt NS, Broglie LA, Diaz M, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hayashi RJ, Hematti P, Hildebrandt GC, Inamoto Y, Kamble RT, Koo J, Lazarus HM, Mayo SJ, Mehta PA, Myers KC, Nishihori T, Prestidge T, Rotz SJ, Savani BN, Schears RM, Sharma A, Stenger E, Ustun C, Williams KM, Vrooman LM, Satwani P, Phelan R.
The Lancet. Child & Adolescent Health. 2024, Aug 30: (): . doi: 10.1016/S2352-4642(24)00167-6. Epub 2024, Aug 30. PMCID:.
PubMed
PMID: 39217999
Abstract